EconPapers    
Economics at your fingertips  
 

Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals

Paul Koenen, Susanne Heinzel, Emma M. Carrington, Lina Happo, Warren S. Alexander, Jian-Guo Zhang, Marco J. Herold, Clare L. Scott, Andrew M. Lew, Andreas Strasser and Philip D. Hodgkin ()
Additional contact information
Paul Koenen: The Walter and Eliza Hall Institute for Medical Research
Susanne Heinzel: The Walter and Eliza Hall Institute for Medical Research
Emma M. Carrington: The Walter and Eliza Hall Institute for Medical Research
Lina Happo: The Walter and Eliza Hall Institute for Medical Research
Warren S. Alexander: The Walter and Eliza Hall Institute for Medical Research
Jian-Guo Zhang: The Walter and Eliza Hall Institute for Medical Research
Marco J. Herold: The Walter and Eliza Hall Institute for Medical Research
Clare L. Scott: The Walter and Eliza Hall Institute for Medical Research
Andrew M. Lew: The Walter and Eliza Hall Institute for Medical Research
Andreas Strasser: The Walter and Eliza Hall Institute for Medical Research
Philip D. Hodgkin: The Walter and Eliza Hall Institute for Medical Research

Nature Communications, 2013, vol. 4, issue 1, 1-10

Abstract: Abstract Two major processes govern T cell proliferation and survival: interleukin-7-mediated homeostasis and antigen-induced selection. How cells transit between the two states is unknown. Here we show that T cell receptor ligation actively inhibits homeostatic survival signals while initiating a new, dominant survival programme. This switch is mediated by a change in the expression of pro- and anti-apoptosis proteins through the downregulation of Bcl-2 and the induction of Bim, A1 and Bcl-xL. Calcineurin inhibitors prevent the initiation of the new survival programme, while permitting the dominant repression of Bcl-2. Thus, in the presence of these drugs the response to antigen receptor ligation is cell death. Our results identify a molecular switch that can serve as an attractive target for inducing antigen-specific tolerance in treating autoimmune disease patients and transplant recipients.

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms2719 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2719

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms2719

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2719